E
Kalaris Therapeutics, Inc. KLRS
$3.08 $0.5220.31% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 06/30/2024
Total Cash And Short-Term Investments -12.42% --
Total Receivables -- --
Inventory -- --
Prepaid Expenses 165.00% --
Finance Division Loans and Leases Current -- --
Total Finance Division Other Current Assets -- --
Other Current Assets -- --
Total Current Assets -10.31% --

Total Current Assets -10.31% --
Net Property, Plant & Equipment -- --
Long-term Investments -- --
Goodwill -- --
Total Other Intangibles -- --
Finance Div Loans & Leases LT -- --
Total Finance Div Other LT Assets -- --
Total Other Assets 30.88% --
Total Assets -9.94% --

Total Accounts Payable 55.01% --
Total Accrued Expenses -15.62% --
Short-term Debt -- --
Current Portion of Long-Term Debt/Capital Leases -- --
Finance Division Debt Current -- --
Total Finance Division Other Current Liabilities -38.26% --
Total Other Current Liabilities -38.26% --
Total Current Liabilities 7.13% --

Total Current Liabilities 7.13% --
Long-Term Debt -- --
Short-term Debt -- --
Capital Leases -- --
Finance Division Debt Non Current -- --
Total Finance Division Other Non Current Liabilities -- --
Total Other Liabilities 0.00% --
Total Liabilities 1.30% --

Common Stock & APIC 0.31% --
Retained Earnings -8.95% --
Treasury Stock & Other -- --
Total Common Equity -16.84% --

Preferred Stock Redeemable -- --
Preferred Stock Non Redeemable -- --
Preferred Stock Convertible -- --
Preferred Stock, Others -- --
Total Preferred Equity -- --

Total Common Equity -16.84% --
Total Preferred Equity -- --
Total Minority Interest -- --
Total Equity -16.84% --